AE Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
AE Wealth Management's XENE Position: Q3 2026 in Review
AE Wealth Management opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 6,437 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #1695 among its holdings.
286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- AE Wealth Management held 6,437 shares of Xenon Pharmaceuticals worth $239K as of Q3 2026.
- Xenon Pharmaceuticals was a new AE Wealth Management position in Q3 2026.
- Xenon Pharmaceuticals made up ﹤0.01% of AE Wealth Management's portfolio in Q3 2026, its #1695 holding.
- 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on AE Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.